These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30635050)

  • 1. Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia.
    Pan T; Liu H; Fang Y; Wei Z; Gu S; Fang G; Liu Y; Luo Y; Guo D; Xu X; Chen B; Jiang J; Yang J; Shi Z; Zhu T; Shi Y; Liu P; Dong Z; Fu W
    Stem Cell Res Ther; 2019 Jan; 10(1):15. PubMed ID: 30635050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with "No-Option" Critical Limb Ischaemia.
    Kyselovic J; Adamičková A; Gažová A; Valášková S; Chomaničová N; Červenák Z; Madaric J
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.
    Madaric J; Klepanec A; Valachovicova M; Mistrik M; Bucova M; Olejarova I; Necpal R; Madaricova T; Paulis L; Vulev I
    Stem Cell Res Ther; 2016 Aug; 7(1):116. PubMed ID: 27530339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.
    Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J
    Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified CD34
    Dong Z; Pan T; Fang Y; Wei Z; Gu S; Fang G; Liu Y; Luo Y; Liu H; Zhang T; Hu M; Guo D; Xu X; Chen B; Jiang J; Yang J; Shi Z; Zhu T; Shi Y; Liu P; Fu W
    EBioMedicine; 2018 Sep; 35():46-57. PubMed ID: 30172703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.
    Kajiguchi M; Kondo T; Izawa H; Kobayashi M; Yamamoto K; Shintani S; Numaguchi Y; Naoe T; Takamatsu J; Komori K; Murohara T
    Circ J; 2007 Feb; 71(2):196-201. PubMed ID: 17251666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical limb ischaemia and the response to bone marrow-derived cell therapy according to tcPO
    Maufus M; Sevestre-Pietri MA; Sessa C; Pignon B; Egelhofer H; Dupas S; Nguyen P; Genty C; Pernod G
    Vasa; 2017 Jan; 46(1):23-28. PubMed ID: 27869551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia.
    Moriya J; Minamino T; Tateno K; Shimizu N; Kuwabara Y; Sato Y; Saito Y; Komuro I
    Circ Cardiovasc Interv; 2009 Jun; 2(3):245-54. PubMed ID: 20031722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma　- Subanalysis of the Long-Term Clinical Outcomes Survey.
    Shoji K; Yanishi K; Yoshimi R; Hamada N; Kondo K; Fujimoto K; Nakajima H; Kuwahara K; Higashi Y; Fukumoto Y; Murohara T; Matoba S;
    Circ J; 2019 Feb; 83(3):662-671. PubMed ID: 30726805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products.
    Tournois C; Pignon B; Sevestre MA; Al-Rifai R; Creuza V; Poitevin G; François C; Nguyen P
    Cytotherapy; 2017 Feb; 19(2):299-310. PubMed ID: 27914820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia.
    Madaric J; Valachovicova M; Paulis L; Pribojova J; Mateova R; Sebekova K; Postulkova L; Madaricova T; Bucova M; Mistrik M; Vulev I
    Stem Cell Res Ther; 2017 Jul; 8(1):165. PubMed ID: 28697789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive values of transcutaneous oxygen tension for above-the-ankle amputation in diabetic patients with critical limb ischemia.
    Faglia E; Clerici G; Caminiti M; Quarantiello A; Curci V; Morabito A
    Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):731-6. PubMed ID: 17296318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells.
    Li S; Zhou B; Han ZC
    Thromb Haemost; 2006 Feb; 95(2):301-11. PubMed ID: 16493493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia.
    Sun L; Wu L; Qiao Z; Yu J; Li L; Li S; Liu Q; Hu Y; Xu N; Huang P
    Cytotherapy; 2014 Aug; 16(8):1110-6. PubMed ID: 24834816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Clinical Outcomes Survey of Bone Marrow-Derived Cell Therapy in Critical Limb Ischemia in Japan.
    Kondo K; Yanishi K; Hayashida R; Shintani S; Shibata R; Murotani K; Ando M; Mizuno M; Fujiwara T; Murohara T; Matoba S;
    Circ J; 2018 Mar; 82(4):1168-1178. PubMed ID: 29386474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible predictors of poor angiogenesis after hematopoietic stem cell autograft for lower limb ischemia.
    Gómez RA; Fernández JD; Cabrera M; Marrero I; Ramírez N; Alvarez I
    MEDICC Rev; 2012 Jul; 14(3):31-6. PubMed ID: 22869247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia.
    Smadja DM; Duong-van-Huyen JP; Dal Cortivo L; Blanchard A; Bruneval P; Emmerich J; Gaussem P
    Cytotherapy; 2012 Feb; 14(2):232-9. PubMed ID: 22040109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of CD34
    Pan T; Wei Z; Fang Y; Dong Z; Fu W
    Vasc Med; 2018 Jun; 23(3):219-231. PubMed ID: 29457540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia.
    Kum S; Tan YK; Schreve MA; Ferraresi R; Varcoe RL; Schmidt A; Scheinert D; Mustapha JA; Lim DM; Ho D; Tang TY; Alexandrescu VA; Mutirangura P
    J Endovasc Ther; 2017 Oct; 24(5):619-626. PubMed ID: 28697694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE; Sciacca V
    Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.